Research Output per year
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 2007 2019
Dose-adjusted EPOCH-R therapy in MYC-rearranged diffuse large B-cell lymphoma: not yet the standard of care
Casan, J. ML., Barraclough, A., Shortt, J. & Hawkes, E. A., 1 Mar 2019, In : The Lancet Haematology. 6, 3, p. e119 1 p.Research output: Contribution to journal › Letter › Other › peer-review
Chemoimmunotherapy may not be dead yet in chronic lymphocytic leukemia, but fludarabine plus cyclophosphamide plus rituximab is potentially facing life support
Opat, S. & Hawkes, E. A., 20 Dec 2017, In : Journal of Clinical Oncology. 35, 36, p. 4093-4094 2 p.Research output: Contribution to journal › Letter › Other › peer-review
Efficacy and toxicity of PACEBOM chemotherapy in relapsed/refractory aggressive lymphoma in the rituximab era
Tamjid, B., Mckendrick, J., Schwarer, A., Doig, R., James, P., Hosking, P. & Hawkes, E. A., 1 Jun 2017, In : Asia-Pacific Journal of Clinical Oncology. 13, 3, p. 226-233 8 p.Research output: Contribution to journal › Article › Research › peer-review
Is upfront escalated BEACOPP for advanced Hodgkin lymphoma becoming a distant memory?
Hawkes, E. A., Chong, G. & Grigg, A., 20 Jan 2017, In : Journal of Clinical Oncology. 35, 3, p. 371-372 2 p.Research output: Contribution to journal › Letter › Other › peer-review
Outcomes for transformed follicular lymphoma in the rituximab era: the Royal Marsden experience 2003–2013
Gleeson, M., Hawkes, E. A., Peckitt, C., Wotherspoon, A., Attygalle, A., Sharma, B., Du, Y., Ethell, M., Potter, M., Dearden, C., Horwich, A., Chau, I. & Cunningham, D., 3 Aug 2017, In : Leukemia and Lymphoma. 58, 8, p. 1805-1813 9 p.Research output: Contribution to journal › Article › Research › peer-review